|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.600
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.271
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.217
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.151
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.149
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.127
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.124
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.124
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.119
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.114
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.113
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.106
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.105
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.101
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.097
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.096
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.095
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.094
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.093
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.092
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.091
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.089
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.087
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.087
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.085
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.085
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.085
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.081
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.081
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.080
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.079
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.078
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.077
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.077
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.076
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.074
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.074
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.074
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.073
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.072
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.069
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.067
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.065
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.062
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.061
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.061
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.059
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.058
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.058
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.058
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.058
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.057
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.057
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.057
|
|
|
|
recognition of apoptotic cell
|
GO:0043654 |
3 |
0.056
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.056
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.056
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.055
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.055
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.055
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.055
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.054
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.054
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.053
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.052
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.051
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.049
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.049
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.049
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.048
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.048
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.048
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.047
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.047
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.046
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.046
|
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.046
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.045
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.044
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.044
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.044
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.044
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.043
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.043
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.043
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.043
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.042
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.042
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.042
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.041
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.041
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.041
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.040
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.040
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.039
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.039
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.039
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.038
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.038
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.038
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.037
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.037
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.037
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.037
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.036
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.036
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.036
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.036
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.035
|
|
|
|
ascending aorta morphogenesis
|
GO:0035910 |
3 |
0.035
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.035
|
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.034
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.034
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.034
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.033
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.033
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.032
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.032
|
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.032
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.031
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.031
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.031
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.031
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.031
|
|
|
|
negative regulation of chemotaxis
|
GO:0050922 |
11 |
0.030
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.030
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.030
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.030
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.030
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.030
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.029
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.029
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.029
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.029
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.029
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.029
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.029
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.029
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.029
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.028
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.028
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.028
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.028
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.027
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.027
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.027
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.027
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.027
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.027
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.027
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.027
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.026
|
|
|
|
lateral ganglionic eminence cell proliferation
|
GO:0022018 |
1 |
0.026
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.026
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.026
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.026
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.026
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.026
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.026
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.026
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.026
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.025
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.025
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.025
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.025
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.025
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.025
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.025
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.025
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.025
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.024
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.024
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.024
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.024
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.024
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.024
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.024
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.023
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.023
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.023
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.023
|
|
|
|
negative regulation of nodal signaling pathway
|
GO:1900108 |
3 |
0.023
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.023
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.023
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.023
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.023
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.023
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.022
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.022
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.022
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.022
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.022
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.022
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.022
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.022
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.022
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.022
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.022
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.022
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.021
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.021
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.021
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.021
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.021
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.021
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.021
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.021
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.021
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.021
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.020
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.020
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.020
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.020
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.020
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.020
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.020
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.020
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.020
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.020
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.020
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.020
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.019
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.019
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.019
|
|
|
|
negative regulation of lipoprotein lipase activity
|
GO:0051005 |
1 |
0.019
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.019
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.019
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.019
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.019
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.019
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.018
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.018
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.018
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.018
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.018
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.018
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.018
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.018
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.018
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.018
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.018
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.018
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.018
|
|
|
|
insulin processing
|
GO:0030070 |
2 |
0.018
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.018
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.018
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.018
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.018
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.017
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.017
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.017
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.017
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.017
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.017
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.017
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.017
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.017
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.017
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.017
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
regulation of phosphatidylcholine biosynthetic process
|
GO:2001245 |
2 |
0.017
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.017
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.017
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.017
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.016
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.016
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.016
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.016
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.016
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.016
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.016
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.016
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.016
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.016
|
|
|
|
sequestering of bmp in extracellular matrix
|
GO:0035582 |
3 |
0.016
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.016
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.016
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.016
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.016
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.016
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.016
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.016
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.016
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.015
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.015
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.015
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.015
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.015
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.015
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.015
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.015
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.015
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.015
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.015
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.015
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.015
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.015
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.015
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.015
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.015
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.014
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.014
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.014
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.014
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.014
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.014
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.014
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.014
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.014
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.014
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.014
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
21 |
0.014
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.014
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.014
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.014
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.014
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.014
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.014
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.014
|
|
|
|
ureter urothelium development
|
GO:0072190 |
3 |
0.014
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.014
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.014
|
|
|
|
frontal suture morphogenesis
|
GO:0060364 |
2 |
0.014
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.014
|
|
|
|
face development
|
GO:0060324 |
38 |
0.014
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.014
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.014
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.014
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.014
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.014
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.014
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.013
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.013
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.013
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.013
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.013
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.013
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.013
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.013
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.013
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.013
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.013
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.013
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.013
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.013
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.013
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.013
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.013
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.013
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.013
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.013
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.013
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.013
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.013
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.013
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.013
|
|
|
|
positive regulation of adiponectin secretion
|
GO:0070165 |
1 |
0.013
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.013
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.013
|
|
|
|
spinal cord ventral commissure morphogenesis
|
GO:0021965 |
2 |
0.013
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.012
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.012
|
|
|
|
regulation of cell growth involved in cardiac muscle cell development
|
GO:0061050 |
3 |
0.012
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.012
|
|
|
|
negative regulation of b cell receptor signaling pathway
|
GO:0050859 |
4 |
0.012
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.012
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.012
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.012
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.012
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.012
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.012
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.012
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.012
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.012
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.012
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.012
|
|
|
|
tendon development
|
GO:0035989 |
6 |
0.012
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.012
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.012
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.012
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.012
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.012
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.012
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.012
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.012
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.012
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.012
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.012
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.011
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.011
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.011
|
|
|
|
negative regulation of osteoclast differentiation
|
GO:0045671 |
12 |
0.011
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.011
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.011
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.011
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.011
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.011
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.011
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.011
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.011
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.011
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.011
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.011
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.011
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.011
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.011
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.011
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.011
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.011
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.011
|
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.011
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.011
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.011
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.011
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.011
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.011
|
|
|
|
positive regulation of rho protein signal transduction
|
GO:0035025 |
7 |
0.011
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.011
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.011
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.011
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.011
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.011
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.011
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.011
|
|
|
|
negative regulation of embryonic development
|
GO:0045992 |
22 |
0.011
|
|
|
|
focal adhesion assembly
|
GO:0048041 |
19 |
0.011
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.010
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.010
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.010
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.010
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.010
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.010
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.010
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.010
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.010
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.010
|
|
|
|
oligosaccharide biosynthetic process
|
GO:0009312 |
7 |
0.010
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.010
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.010
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.010
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.010
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.010
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.010
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.010
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.010
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.010
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.010
|
|